Active Ingredient: BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
Proprietary Name: WYNZORA
Dosage Form; Route of Administration: CREAM; TOPICAL
Strength: 0.064%;0.005%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N213422
Product Number: 001
Approval Date: Jul 20, 2020
Applicant Holder Full Name: MC2 THERAPEUTICS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information